TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 SEK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
691
|
1,112
|
1,077 |
| Financial expenses |
47
|
0
|
1 |
| Earnings before taxes |
62
|
400
|
633 |
| EBITDA |
108
|
105
|
102 |
| Total assets |
3,238
|
3,665
|
3,655 |
| Current assets |
293
|
343
|
329 |
| Current liabilities |
175
|
312
|
334 |
| Equity capital |
2,896
|
3,124
|
3,070 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
89.4%
|
85.2%
|
84.0% |
| Turnover per employee |
691
|
1,112
|
1,077 |
| Profit as a percentage of turnover |
9.0%
|
36.0%
|
58.8% |
| Return on assets (ROA) |
3.4%
|
10.9%
|
17.3% |
| Current ratio |
167.4%
|
109.9%
|
98.5% |
| Return on equity (ROE) |
2.1%
|
12.8%
|
20.6% |
| Change turnover |
-421
|
35
|
-326 |
| Change turnover % |
-38%
|
3%
|
-23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.